Lazard Asset Management »

Legend Biotech 2 Adr Rep Ord shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 590 0.00
2023-09-30 $0 569 0.00
2023-06-30 $0 544 0.00
2023-03-31 $0 526 0.00
2022-12-31 $0 689 0.00

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Alphabet Inc A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Accenture Common Stock (ACN)
Intercontinen Common Stock (ICE)
Unitedhealth Gr Common Stock (UNH)
Aon Plc/ireland Common Stock (AON)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Analog Devices Common Stock (ADI)
Mcdonalds Corp Common Stock (MCD)
John & John Common Stock (JNJ)
Amer Express Common Stock (AXP)

View all positions for Lazard Asset Management

Top funds holding Legend Biotech 2 Adr Rep Ord

T. Rowe Price Associates
RA Capital Management
Hillhouse Capital Advisors
Wellington Management Company
Massachusetts Financial Services
Paradigm Biocapital Advisors
Henderson Group
Westfield Capital Management Company
Holocene Advisors
Federated Investors
Alliancebernstein
TimesSquare Capital Management
Arrowpoint Asset Management
Matthews International Capital Management
Avidity Partners Management

View all funds holding Legend Biotech 2 Adr Rep Ord